Free Trial
NYSE:MLSS

Milestone Scientific (MLSS) Stock Price, News & Analysis

Milestone Scientific logo
$1.09 +0.08 (+7.92%)
Closing price 03/25/2025 04:00 PM Eastern
Extended Trading
$1.07 -0.02 (-1.83%)
As of 03/25/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Milestone Scientific Stock (NYSE:MLSS)

Key Stats

Today's Range
$1.01
$1.09
50-Day Range
$0.91
$1.33
52-Week Range
$0.54
$1.39
Volume
126,610 shs
Average Volume
136,532 shs
Market Capitalization
$84.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.25
Consensus Rating
Buy

Company Overview

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Remove Ads

Milestone Scientific Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
17th Percentile Overall Score

MLSS MarketRank™: 

Milestone Scientific scored higher than 17% of companies evaluated by MarketBeat, and ranked 876th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Milestone Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Milestone Scientific has received no research coverage in the past 90 days.

  • Read more about Milestone Scientific's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Milestone Scientific is -15.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Milestone Scientific is -15.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Milestone Scientific has a P/B Ratio of 9.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for MLSS.
  • Dividend Yield

    Milestone Scientific does not currently pay a dividend.

  • Dividend Growth

    Milestone Scientific does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for MLSS.
  • News Sentiment

    Milestone Scientific has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Milestone Scientific this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Milestone Scientific insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    24.75% of the stock of Milestone Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 5.79% of the stock of Milestone Scientific is held by institutions.

  • Read more about Milestone Scientific's insider trading history.
Receive MLSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter.

MLSS Stock News Headlines

Milestone Scientific announces CompuFlo rollout at Pain Doctors Medical
Trump’s Final Plan
Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.
See More Headlines

MLSS Stock Analysis - Frequently Asked Questions

Milestone Scientific's stock was trading at $0.96 at the beginning of the year. Since then, MLSS stock has increased by 13.5% and is now trading at $1.09.
View the best growth stocks for 2025 here
.

Milestone Scientific Inc. (NYSE:MLSS) announced its quarterly earnings data on Thursday, August, 15th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.01. The firm had revenue of $1.85 million for the quarter. Milestone Scientific had a negative trailing twelve-month return on equity of 60.26% and a negative net margin of 52.01%.

Milestone Scientific's top institutional shareholders include Bridgeway Capital Management LLC (0.47%), Carnegie Investment Counsel (0.22%), Renaissance Technologies LLC (0.16%) and Concourse Financial Group Securities Inc.. Insiders that own company stock include Leonard Osser, Neal I Goldman, Michael Mcgeehan and Leslie Bernhard.
View institutional ownership trends
.

Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Milestone Scientific investors own include Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), AUO (AUOTY), iShares Micro-Cap ETF (IWC), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/15/2024
Today
3/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NYSE:MLSS
Employees
30
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.25
High Stock Price Target
$1.25
Low Stock Price Target
$1.25
Potential Upside/Downside
+14.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-6,930,000.00
Pretax Margin
-52.21%

Debt

Sales & Book Value

Annual Sales
$8.88 million
Price / Cash Flow
N/A
Book Value
$0.11 per share
Price / Book
9.91

Miscellaneous

Free Float
58,614,000
Market Cap
$84.90 million
Optionable
Optionable
Beta
1.41
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NYSE:MLSS) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners